Zhongji Innolight Balance Sheet Health
Financial Health criteria checks 6/6
Zhongji Innolight has a total shareholder equity of CN¥22.0B and total debt of CN¥2.8B, which brings its debt-to-equity ratio to 12.5%. Its total assets and total liabilities are CN¥31.6B and CN¥9.6B respectively. Zhongji Innolight's EBIT is CN¥6.7B making its interest coverage ratio -76.1. It has cash and short-term investments of CN¥7.2B.
Key information
12.52%
Debt to equity ratio
CN¥2.75b
Debt
Interest coverage ratio | -76.1x |
Cash | CN¥7.23b |
Equity | CN¥21.98b |
Total liabilities | CN¥9.60b |
Total assets | CN¥31.58b |
Recent financial health updates
Is Zhongji Innolight (SZSE:300308) A Risky Investment?
Feb 10We Think Zhongji Innolight (SZSE:300308) Can Stay On Top Of Its Debt
Sep 13Recent updates
Investors Shouldn't Overlook Zhongji Innolight's (SZSE:300308) Impressive Returns On Capital
Mar 02Is Zhongji Innolight (SZSE:300308) A Risky Investment?
Feb 10Is There An Opportunity With Zhongji Innolight Co., Ltd.'s (SZSE:300308) 42% Undervaluation?
Jan 29Do Zhongji Innolight's (SZSE:300308) Earnings Warrant Your Attention?
Dec 30Returns on Capital Paint A Bright Future For Zhongji Innolight (SZSE:300308)
Dec 02What Is Zhongji Innolight Co., Ltd.'s (SZSE:300308) Share Price Doing?
Oct 13After Leaping 42% Zhongji Innolight Co., Ltd. (SZSE:300308) Shares Are Not Flying Under The Radar
Sep 30We Think Zhongji Innolight (SZSE:300308) Can Stay On Top Of Its Debt
Sep 13Earnings Beat: Zhongji Innolight Co., Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 29Zhongji Innolight Co., Ltd.'s (SZSE:300308) 29% Jump Shows Its Popularity With Investors
Jul 12Financial Position Analysis
Short Term Liabilities: 300308's short term assets (CN¥20.6B) exceed its short term liabilities (CN¥7.5B).
Long Term Liabilities: 300308's short term assets (CN¥20.6B) exceed its long term liabilities (CN¥2.1B).
Debt to Equity History and Analysis
Debt Level: 300308 has more cash than its total debt.
Reducing Debt: 300308's debt to equity ratio has reduced from 25.2% to 12.5% over the past 5 years.
Debt Coverage: 300308's debt is well covered by operating cash flow (170%).
Interest Coverage: 300308 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/06/17 15:30 |
End of Day Share Price | 2025/06/17 00:00 |
Earnings | 2025/03/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Zhongji Innolight Co., Ltd. is covered by 34 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Kexin Zhu | BofA Global Research |
Kexin Zhu | BofA Global Research |
Lin Su | CCB International Securities Limited |